I’ve spent years running a rehab clinic. In that time, I’ve watched prior authorizations delay care for weeks. I’ve watched patients discharge early because they hit their insurance cap — not because they were done getting better. I’ve watched clinicians spend more time on documentation and billing compliance than on actual clinical thinking. I’ve also spent years on the other side of that equation — consulting and advising health tech companies building the tools that enable direct-to-patient care. Telehealth platforms, remote monitoring companies, digital health startups trying to route around the traditional system. I’ve seen what those companies get right and where the pitch diverges from the reality.
None of the dysfunction in traditional healthcare is accidental. The third-party payer model wasn’t designed to serve patients or providers. It was designed to manage financial risk for employers and insurers. The care was always secondary to the contract.
That context matters when you read about the rise of direct-to-patient healthcare — because the conversation usually skips it.
What “Direct-to-Patient” Actually Means
The term gets used loosely. At its core, direct-to-patient (DTP) healthcare refers to any model that eliminates the insurance intermediary and connects patients directly with providers for a transparent, predetermined price.
Cash-pay physical therapy is DTP. Direct primary care is DTP. Telehealth platforms that charge a flat monthly fee are DTP. Compounding pharmacies that ship custom medications directly to patients are DTP.
What’s changed recently isn’t the concept. It’s the infrastructure around it.
Telehealth platforms, AI-driven intake tools, remote monitoring devices, and consumer-grade health apps have all lowered the operational cost of going direct. What once required a full concierge practice with wealthy clientele can now be structured around a leaner, tech-enabled model that serves a broader market.
The US healthcare system spent $4.9 trillion in 2023 — roughly $14,570 per person. The outcomes don’t justify that number. Any clinician who has worked inside that system already knows where the waste lives.
What DTP Gets Right
Cost transparency. This is the most straightforward win. Hidden fees, surprise bills, and confusing coverage limitations are among the biggest frustrations patients report with traditional healthcare. DTP models address this by publishing prices upfront. A patient knows what they’re paying before they schedule. That’s not revolutionary. It’s just honest.
For providers, it’s also cleaner. You treat the patient. They pay you. You don’t spend 90 days waiting on a reimbursement that may come back denied.
Personalization, within reason. The DTP pitch often leans heavily on personalized care — tailored treatment plans, precision medicine, AI-driven health recommendations. Some of that is real. DTP platforms can integrate wearable data, health history, and predictive tools to build care plans that a ten-minute insurance-reimbursed visit can’t accommodate.
In rehab specifically, this shows up in remote therapeutic monitoring and asynchronous coaching models. A patient doesn’t need to come in three times a week for six weeks if a structured home program with check-ins produces the same outcome. DTP economics make that model viable in a way that fee-for-service doesn’t reward.
Provider flexibility. Clinicians in traditional practice spend enormous energy navigating payer requirements that have nothing to do with clinical quality. DTP removes that layer. A provider in a cash-pay model can structure visits, treatment duration, and follow-up protocols based on clinical judgment — not on what the CPT code allows.
That’s not a small thing. Clinician burnout has a lot of contributing factors, but administrative burden tied to insurance compliance is near the top of every list.
What DTP Gets Wrong — or at Least Overstates
The access problem. Direct-to-patient models work best for patients who can pay out of pocket, are digitally capable, and can self-advocate in a healthcare context. That describes a specific demographic. It doesn’t describe the patients who carry the highest burden of chronic disease in this country.
Lower-income adults, rural populations, patients managing multiple comorbidities with limited health literacy — these are not the people the DTP model was designed around. That’s not an indictment. Every business model has a target customer. But the framing of DTP as a solution to healthcare’s access problem is misleading. It’s a solution for some patients. A different and harder problem remains for everyone else.
The prevention narrative. DTP has gotten enough mainstream attention that Forbes has covered it in detail. The prevailing argument is that these models shift healthcare from reactive to proactive — from treating illness to preventing it. That’s a reasonable aspiration. It’s also been a reasonable aspiration in healthcare for about forty years with limited structural progress.
Prevention requires sustained engagement, behavior change, and long-term follow-through. A clean app interface and a personalized wellness plan don’t reliably produce those things. The patients most likely to engage with a DTP prevention platform are already the patients most likely to take care of their health. That’s a real benefit for those individuals. It doesn’t move the population-level needle.
The tech as solution framing. There’s a pattern in healthcare innovation writing where the presence of AI, wearables, or genomics signals that a real problem is being solved. Sometimes it is. But the structural problem in US healthcare isn’t a technology deficit. It’s an incentive misalignment. Technology applied inside misaligned incentives tends to make the existing system more efficient at doing the wrong thing.
DTP sidesteps some of those incentives. That’s genuinely useful. But it doesn’t resolve them at scale.
What This Means for Rehab Clinic Owners
The DTP wave creates real options for rehab practitioners that didn’t exist a decade ago. The question is how to think about them practically.
Cash-pay isn’t all-or-nothing. Most clinic owners I talk to treat the cash-pay vs. insurance question as binary. It doesn’t have to be. A hybrid model — insurance-based care for the core caseload, a cash-pay track for services the payers don’t cover well — can reduce dependence on any single revenue source without abandoning the patients who need insurance to access care at all.
Wellness programs, performance training, group classes, remote monitoring packages — these are services patients want and payers don’t reimburse. They’re also services where the direct-to-patient model fits cleanly.
The relationship is the differentiator. DTP platforms win on convenience and transparency. Where they can’t compete with a clinic-based provider is on the depth of the clinical relationship. A patient who has been coming to your clinic for years, who you know by name, whose history you know, who trusts your judgment — that’s not replaceable by an app.
The clinicians who get squeezed in a DTP future are the ones who were already functioning as interchangeable units inside large insurance-dependent systems. The ones who built genuine patient relationships are harder to displace.
You need to understand your unit economics. This is the piece most clinicians aren’t taught. If you don’t know your cost per visit, your reimbursement per payer, your contribution margin by service line — you can’t make a rational decision about which business model actually works for your practice. The DTP conversation is ultimately a financial modeling question as much as a clinical one.
The Bigger Picture
Direct-to-patient healthcare won’t replace the traditional system. It’ll run alongside it, serving a different population, creating different incentives, and producing different outcomes.
The gap between those two systems — who has access to which, and who falls through the space between them — is where the harder policy conversation lives. That conversation is mostly being avoided in the enthusiasm around the DTP growth story.
For clinicians and clinic owners, the practical question is narrower. Can you build a revenue model that gives you more clinical and financial autonomy, without walking away from the patients who need you most?
Some can. The ones who figure it out sooner will have more options than the ones still waiting for payer rates to improve.
Connect with Me
My Books
- From Clinician to Something More: A Healthcare Professional’s Guide to Business, Leadership, and Life Beyond the Clinic
- From Clinician to Owner: A Healthcare Practice Owner’s Field Guide
- Better Outcomes: A Guide to Humanizing Healthcare
Are You Ready to Take Your Healthcare Business to the Next Level?
Navigating the complexities of the healthcare industry requires deep expertise, actionable insights, and a focus on sustainability. That’s exactly what we deliver. Whether you’re looking to improve patient engagement, streamline operations, or develop a winning go-to-market strategy, I help you move the needle and achieve lasting results. If you want to learn more, reach out. I’d love to talk with you about how I can help you Leverage Objective Advice & Insight, Focused Knowledge, and Industry Expertise to Move the Needle for your Healthcare Business or Organization.
Work With Me
Are you building something innovative in healthcare—like a digital health product, service, or platform that’s aiming to truly improve the patient experience?
I help healthcare startups, SaaS platforms, and forward-thinking provider organizations develop clear positioning strategies, identify high-value offers, and build go-to-market plans that actually resonate with both users and buyers.
Whether you're launching a new product, scaling an existing service, or navigating digital transformation, I bring 12+ years of experience across clinical operations, healthcare innovation, and strategic development.
How I help:
- Clarify your product/service positioning so customers “get it”
- Align your offer with real market needs
- Build a Digital Health Roadmap to scale your healthcare organization effectively
- Support business development with industry-informed strategy
I’ve consulted on projects from multi-million-dollar state initiatives to early-stage product launches. My work’s been featured in Forbes, and I also speak at healthcare events and conferences on topics like innovation, digital health, and humanizing care. I also speak and train at healthcare conferences, events, and organizations on topics related to technology-enabled care, healthcare innovation, healthcare positioning, and humanizing the healthcare experience.
Recent Comments